DV1 TFA is a selective antagonist for CXC chemokine receptor 4 (CXCR4). DV1 TFA exhibits antiviral activity by blocking HIV-1 entry through the CXCR4 co-receptor[1].
Molecular Weight:
2424.85 (free base)
Purity:
98.53
Formula:
C108H170N34O26S2.xC2HF3O2
Target:
CXCR,HIV
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted